Cipla
Sudhir Sharma has extensive experience in the pharmaceutical industry, currently serving as the Business Unit Head for Sales & Marketing at Cipla since January 2022. Prior to this role, Sudhir held the position of General Manager for Sales & Marketing at Alembic Pharmaceuticals Limited from February 2020 to January 2022. Sudhir's tenure at Glenmark Pharmaceuticals Ltd. spanned over a decade, where roles included General Manager-Sales, Business Head, Sales Manager, and Zonal Sales Manager, responsible for the All India Business and sales in multiple regions. Earlier career highlights include serving as Regional Sales Manager at J.B. Chemicals & Pharmaceuticals Limited and holding positions as Medical Representative and District Sales Manager at Unichem Laboratories Limited. Sudhir completed a Bachelor of Science degree in Physics, Chemistry, and Mathematics from Dayal Singh College, Delhi University, between 1992 and 1995.
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.